Home > Insider Trading > Filing (0000905718-14-000649)

Filing Details

Accession Number:: 0000905718-14-000649
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-03 09:45:58
Reporting Period:: 2013-08-14

Filing Date:: 2014-10-03
Accepted Time:: 2014-10-03 09:45:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070698	Raptor Pharmaceutical Corp	RPTP	Pharmaceutical Preparations (2834)	860883978

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614443	Portfolio Segregated Trading Hyperion	C/O Tmf Ltd. Grand Pavillion Comm. Ctr 2Nd Fl., 802 West Bay Road, Po Box 10338 Grand Cayman E9 KY1-1003		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.001 Per Share	Disposition	2013-08-14	15,000	$10.70	6,219,000	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2013-08-15	15,000	$11.03	6,204,000	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2013-08-16	15,000	$11.50	6,189,000	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2013-08-19	15,000	$11.51	6,174,000	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2013-08-20	55,000	$12.05	6,119,000	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2013-08-21	25,000	$12.25	6,094,000	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2013-08-22	65,000	$12.64	6,029,000	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2013-08-23	74,300	$13.15	5,954,700	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.001 Per Share	Contracts for Difference	Disposition	2013-08-23	700	$12.90	700	$12.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
421,006			Yes	4	J	Direct

Footnotes

The shares of common stock, $0.001 par value per share (the "Common Shares"), of Raptor Pharmaceutical Corp., a Delaware corporation (the "Company"), reported herein were held by Hyperion Trading Segregated Portfolio (the "Reporting Person"), a segregated portfolio of Strategic Investment Tribes Fund SPC, a Cayman Islands exempted company registered as a segregated portfolio company, managed by Sequoia Asset Management S.A., a company organized under the laws of Switzerland ("Sequoia").
The Common Shares and Contracts for Difference ("CFDs", and together with the Common Shares, the "Securities") reported herein represent transactions undertaken by the Reporting Person. Pursuant to Reg. Section 240.16a-1(a)(1), Sequoia, as the investment manager of the Reporting Person, is not deemed a beneficial owner of the Securities held by the Reporting Person or any other account managed by Sequoia. In the event that Sequoia is deemed a beneficial owner of the Securities held by the Reporting Person or any other account managed by Sequoia, pursuant to Reg. Section 240.16a-1(a)(2), its beneficial ownership is limited to its pecuniary interest, if any, in such Securities.
This price represents the weighted average purchase sale of the Common Shares on August 20, 2013, which were sold in multiple transactions ranging from $11.78 to $12.30, inclusive.
This price represents the weighted average purchase sale of the Common Shares on August 21, 2013, which were sold in multiple transactions ranging from $12.15 to $12.40, inclusive.
This price represents the weighted average purchase sale of the Common Shares on August 22, 2013, which were sold in multiple transactions ranging from $12.42 to $12.90, inclusive.
This price represents the weighted average purchase sale of the Common Shares on August 23, 2013, which were sold in multiple transactions ranging from $12.75 to $13.50, inclusive.
Agreement to sell the difference between purchase price and market value upon conversion.
On August 23, 2013, pursuant to an agreement between the Reporting Person and a securities broker (the "Issuer of the CFDs"), the Reporting Person converted 700 CFDs for $9,030.00, representing a conversion price of $12.90 per CFD, offset by $4,361.00, representing $6.23 per CFD (the purchase price of the CFD). The CFDs do not grant voting rights or dispositive rights over the Common Shares.